Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Simonneau

Showing results (191-200 of 240) with videos related to

Pageof 24
Sort By:
Transplantation|December 1, 1991
Soluble interleukin 2 receptor and neopterin serum levels after lung/heart-lung transplantations--absence of predictive value for late allograft rejectionM Humbert, D Emilie, J Cerrina, et al.
American Journal of Respiratory and Critical Care Medicine|October 13, 2000
Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapyS Eddahibi, M Humbert, S Sediame, et al.
American Journal of Respiratory and Critical Care Medicine|April 14, 2000
Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of FranceF Fraisse, L Holzapfel, J M Couland, et al.
The American Journal of Medicine|September 1, 1995
Increased plasma serotonin in primary pulmonary hypertensionP Hervé, J M Launay, M L Scrobohaci, et al.
The European Respiratory Journal|March 28, 2009
Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertensionL Dewachter, S Adnot, C Guignabert, et al.
British Journal of Clinical Pharmacology|February 1, 1994
Inhibition of gastric alcohol dehydrogenase activity by histamine H2-receptor antagonists has no influence on the pharmacokinetics of ethanol after a moderate doseA Mallat, F Roudot-Thoraval, J F Bergmann, et al.
The European Respiratory Journal|May 22, 1998
Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patientsM Humbert, G Monti, M Fartoukh, et al.
International Journal of Clinical Practice. Supplement|December 24, 2010
Current management approaches to portopulmonary hypertensionL Savale, D S O'Callaghan, R Magnier, et al.
The European Respiratory Journal|February 3, 2005
Survival with first-line bosentan in patients with primary pulmonary hypertensionV V McLaughlin, O Sitbon, D B Badesch, et al.
Circulation|February 1, 1996
Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertensionO Raffy, R Azarian, F Brenot, et al.
Pageof 24

Showing results (191-200 of 240) with videos related to

Sort By:
Pageof 24
Transplantation|December 1, 1991
Soluble interleukin 2 receptor and neopterin serum levels after lung/heart-lung transplantations--absence of predictive value for late allograft rejectionM Humbert, D Emilie, J Cerrina, et al.
American Journal of Respiratory and Critical Care Medicine|October 13, 2000
Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Effect of prostacyclin therapyS Eddahibi, M Humbert, S Sediame, et al.
American Journal of Respiratory and Critical Care Medicine|April 14, 2000
Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of FranceF Fraisse, L Holzapfel, J M Couland, et al.
The American Journal of Medicine|September 1, 1995
Increased plasma serotonin in primary pulmonary hypertensionP Hervé, J M Launay, M L Scrobohaci, et al.
The European Respiratory Journal|March 28, 2009
Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertensionL Dewachter, S Adnot, C Guignabert, et al.
British Journal of Clinical Pharmacology|February 1, 1994
Inhibition of gastric alcohol dehydrogenase activity by histamine H2-receptor antagonists has no influence on the pharmacokinetics of ethanol after a moderate doseA Mallat, F Roudot-Thoraval, J F Bergmann, et al.
The European Respiratory Journal|May 22, 1998
Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patientsM Humbert, G Monti, M Fartoukh, et al.
International Journal of Clinical Practice. Supplement|December 24, 2010
Current management approaches to portopulmonary hypertensionL Savale, D S O'Callaghan, R Magnier, et al.
The European Respiratory Journal|February 3, 2005
Survival with first-line bosentan in patients with primary pulmonary hypertensionV V McLaughlin, O Sitbon, D B Badesch, et al.
Circulation|February 1, 1996
Clinical significance of the pulmonary vasodilator response during short-term infusion of prostacyclin in primary pulmonary hypertensionO Raffy, R Azarian, F Brenot, et al.
Pageof 24